TI
DYN icon

Trexquant Investment’s Dyne Therapeutics DYN Stock Holding History

Trexquant Investment’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$501K Sell
27,641
-73,004
-73% -$1.26M ﹤0.01% 1468
2025
Q4 		$1.97M Sell
100,645
-244,817
-71% -$4.64M 0.02% 997
2025
Q3 		$4.37M Sell
345,462
-16,848
-5% -$192K 0.05% 601
2025
Q2 		$3.45M Buy
362,310
+27,867
+8% +$307K 0.04% 676
2025
Q1 		$3.5M Buy
334,443
+209,065
+167% +$2.99M 0.04% 653
2024
Q4 		$2.95M Buy
125,378
+61,288
+96% +$1.81M 0.03% 714
2024
Q3 		$2.3M Sell
64,090
-17,872
-22% -$711K 0.03% 759
2024
Q2 		$2.89M Buy
81,962
+42,983
+110% +$1.25M 0.04% 595
2024
Q1 		$1.11M Buy
38,979
+16,157
+71% +$365K 0.02% 881
2023
Q4 		$304K Buy
+22,822
New +$223K 0.01% 1246
2023
Q3 		– Sell
-27,380
Closed -$308K – 1544
2023
Q2 		$308K Sell
27,380
-15,089
-36% -$178K 0.01% 1187
2023
Q1 		$489K Buy
42,469
+14,378
+51% +$187K 0.01% 1009
2022
Q4 		$326K Sell
28,091
-8,476
-23% -$98.1K 0.01% 1073
2022
Q3 		$464K Buy
+36,567
New +$419K 0.02% 843
2022
Q1 		– Sell
-20,232
Closed -$241K – 1441
2021
Q4 		$241K Sell
20,232
-7,622
-27% -$107K 0.01% 1039
2021
Q3 		$452K Buy
+27,854
New +$494K 0.04% 577

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Trexquant Investment's DYN Position: Q1 2026 in Review

Trexquant Investment reduced its Dyne Therapeutics (DYN) stake by 73% in Q1 2026, selling an estimated $1.26M and leaving 27,641 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #1468.

Trexquant Investment first reported a position in DYN in Q3 2021 and has held it in 16 quarters since. The position peaked at $4.37M in Q3 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Trexquant Investment held 27,641 shares of Dyne Therapeutics worth $501K as of Q1 2026.
  • Trexquant Investment sold 73,004 Dyne Therapeutics shares in Q1 2026, an estimated $1.26M.
  • Dyne Therapeutics made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1468 holding.
  • Trexquant Investment first reported a position in Dyne Therapeutics in Q3 2021 and has held it in 16 quarters since.
  • Trexquant Investment's Dyne Therapeutics position peaked at $4.37M in Q3 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.